Skip to main content
Ecopipam reduces Tourette’s tics without common side effects in phase 2 trial
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Ecopipam reduces Tourette’s tics without common side effects in phase 2 trial
User login
Username
Password
Reset your password
Specialty
Lead
score
Pediatrics
1
1
Neurology & Neurosurgery
0
0.9
Pharmacist
0
0.8
Concept
Lead
score
Patient Safety
0
0.64
Adverse Effects
0
0.6
Child
0
0.45
Weight Management
0
0.38
Weight Gain
0
0.37
Sleep Disorders
0
0.33
Tourette Syndrome
0
1
Headache
0
0.23
Insomnia
0
0.22
Adolescent Medicine
0
0.15
Metabolism
0
0.15
Movement Disorder
0
0.15
Receptors
0
0.15
Vermont
0
0.15
Antipsychotics
0
0.07
Canada
0
0.07
Clinical Guidelines
0
0.07
Diversity
0
0.07
Dopamine
0
0.07
Electrocardiogram (ECG)
0
0.07
Electrophysiology
0
0.07
Europe
0
0.07
Fatigue
0
0.07
Hospital
0
0.07
Multiple Sclerosis
0
0.07
Primary Care
0
0.07
Social Determinants of Health
0
0.07
Edit Tags